BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17524045)

  • 1. Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection.
    Hopwood M; Treloar C
    J Adv Nurs; 2007 Aug; 59(3):248-54. PubMed ID: 17524045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
    Hopwood M; Treloar C
    Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living with hepatitis C and treatment: the personal experiences of patients.
    Sgorbini M; O'Brien L; Jackson D
    J Clin Nurs; 2009 Aug; 18(16):2282-91. PubMed ID: 19583661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The experience of interferon-based treatments for hepatitis C infection.
    Hopwood M; Treloar C
    Qual Health Res; 2005 May; 15(5):635-46. PubMed ID: 15802540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon treatment for chronic hepatitis C: a family impact study.
    Blacklaws H; Veysey H; Skinner V; Reid RS; Hawken G; Veysey M
    Gastroenterol Nurs; 2009; 32(6):377-83. PubMed ID: 20010228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.
    Mauss S
    J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.
    Smith JP
    Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' experiences related to anti-viral treatment for hepatitis C.
    Fraenkel L; McGraw S; Wongcharatrawee S; Garcia-Tsao G
    Patient Educ Couns; 2006 Jul; 62(1):148-55. PubMed ID: 16098705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
    Sharvadze L; Gochitashvili N; Tophuria A; Bolokadze N; Tsertsvadze T
    Georgian Med News; 2007 Jun; (147):52-5. PubMed ID: 17660602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary angioplasty for heart attack: mismatch between expectations and reality?
    Astin F; Closs SJ; McLenachan J; Hunter S; Priestley C
    J Adv Nurs; 2009 Jan; 65(1):72-83. PubMed ID: 19032516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR; Burton JR; Villamil F; Rosen HR
    Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future management of chronic hepatitis C infection.
    Cross TJ; Antoniades CG; Harrison PM
    Postgrad Med J; 2008 Apr; 84(990):172-6. PubMed ID: 18424572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Aug; 79(8):1095-102. PubMed ID: 17597485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives.
    Stewart BJ; Mikocka-Walus AA; Harley H; Andrews JM
    Int J Nurs Stud; 2012 May; 49(5):560-9. PubMed ID: 22154094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.
    Van Thiel DH; Friedlander L; De Maria N; Molloy PJ; Kania RJ; Colantoni A
    Hepatogastroenterology; 1998; 45(20):328-30. PubMed ID: 9638401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life.
    Lidgren M; Hollander A; Weiland O; Jönsson B
    Scand J Gastroenterol; 2007 Jul; 42(7):867-77. PubMed ID: 17558912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future treatment of chronic hepatitis C.
    Keeffe EB
    Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.